/

Septerna

Discovers and develops oral small molecule drugs targeting GPCRs.

BiotechnologyPharmaceuticals septerna.com ↗

Company facts

Founded: 2019
Employees: 78
Headquarters: United States
Type: Public
Listed: NASDAQ: SEPN